Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

17
Number of overlapping holdings
34.7%
% of PINK's 53 holdings also in BMED
16.2%
% of BMED's 115 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PINK |
Weight in BMED |
Overlap | |
---|---|---|---|---|
INTUITIVE SURGICAL INC | 4.4% | 4.9% | 4.4% | |
GILEAD SCIENCES INC | 5.0% | 3.7% | 3.7% | |
ABBVIE INC | 5.2% | 3.1% | 3.1% | |
ABBOTT LABORATORIES | 2.1% | 2.7% | 2.1% | |
NEUROCRINE BIOSCIENCES INC | 1.6% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to BMED
ELI LILLY & CO | 10.1% | |
ARCUTIS BIOTHERAPEUTICS INC | 7.6% | |
REGENERON PHARMACEUTICALS | 6.6% | |
JOHNSON & JOHNSON | 5.0% | |
UNITEDHEALTH GROUP INC | 4.9% | |
RESMED INC | 4.9% | |
DANAHER CORP | 3.8% | |
PACIRA PHARMACEUTICALS INC | 3.1% | |
PURECYCLE TECHNOLOGIES INC | 3.1% | |
CIGNA CORPORATION | 2.8% |
PINK Underweight Relative to BMED
BOSTON SCIENTIFIC CORP | -4.8% | |
ROCHE HOLDING AG-BR | -3.4% | |
LONZA GROUP AG-REG | -2.7% | |
ARGENX SE ADR | -2.7% | |
MEDTRONIC PLC | -2.3% | |
UCB SA | -2.2% | |
BRISTOL-MYERS SQUIBB CO | -2.1% | |
REPLIGEN CORP | -2.1% | |
WATERS CORP | -2.0% | |
BIO-TECHNE CORPORATION | -1.8% |